Verapamil Hydrochloride Capsule, Delayed Release
Product Images NDC 52536-884

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 52536-884). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wilshire Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (120 mg Capsule Bottle Label)

Principal Display Panel (120 mg Capsule Bottle Label)
Label for Verapamil Hydrochloride Sustained-Release Capsules 120 mg by Wilshire Pharmaceuticals, Inc. The label indicates 100 capsules in the package, prescription only. It includes storage instructions, manufacturing and distribution details, dosage form as sustained-release capsules, and a barcode.*
FDA Label Image

Principal Display Panel (180 mg Capsule Bottle Label)

Principal Display Panel (180 mg Capsule Bottle Label)
Label for Verapamil Hydrochloride Sustained-Release Capsules 180 mg. The label states the product is for prescription use only, with 100 capsules per package. It includes storage instructions, manufacturer Societal CDMO Gainesville, LLC, and distributor Wilshire Pharmaceuticals, Inc. A barcode is also visible on the right side.*
FDA Label Image

Principal Display Panel (240 mg Capsule Bottle Label)

Principal Display Panel (240 mg Capsule Bottle Label)
Label for Verapamil Hydrochloride Sustained-Release Capsules, 240 mg strength, in a container of 100 capsules. The label states it is Rx only and distributed by Wilshire Pharmaceuticals, Inc. It includes storage instructions, manufacturer info for Societal CDMO Gainesville, LLC, and a barcode. The dosage form is oral delayed-release capsules.*
FDA Label Image

Principal Display Panel (360 mg Capsule Bottle Label)

Principal Display Panel (360 mg Capsule Bottle Label)
Label for Verapamil Hydrochloride Sustained-Release Capsules, 360 mg strength. The oral delayed-release capsules come in a package containing 100 capsules. The label shows the NDC 52536-886-01 and states the product is Rx-only. It is manufactured by Societal CDMO Gainesville, LLC and distributed by Wilshire Pharmaceuticals, Inc.*
FDA Label Image

Verapamil Hydrochloride Structural Formula (Verapamil 01)

Verapamil Hydrochloride Structural Formula (Verapamil 01)
Chemical structure of verapamil hydrochloride showing two benzene rings with methoxy groups and a side chain including nitrogen, carbon, and methyl groups, along with the hydrochloride (HCl) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.